| Control group (n=192) | Intrathecal treatment group (n=194) | P value |
---|---|---|---|
Immunosuppressors during hospitalization, n (%) | |||
 Cyclophosphamide | 115(59.9) | 136(70.1) | 0.559 |
 Mycophenolate Mofetil | 42(21.8) | 34(17.5) | 0.374 |
 Calcineurin inhibitors | 10(5.21) | 9(4.64) | 0.819 |
 Other immunosuppressive agents | 3(1.56) | 4(2.06) | 1 |
 Rituximab | 1(0.52) | 2(1.03) | 1 |
 Combination of immunosuppressive agents | 9(4.69) | 6(3.10) | 0.584 |
 None | 12(6.25) | 3(1.55) | 0.018* |
Time of hospitalization (days, median [IQR]) | 24[16.8,30] | 31[20.36] | 0.265 |
Time of follow-up (years, median [IQR]) | 2.51[1.08,3.80] | 2.63[1.18, 4.48] | 0.202 |